Patient Group: White House’s Kidney Disease Focus May Spur Investors

National Kidney Foundation leaders expressed hope signals from the White House that FDA, CMS and the Center for Medicare & Medicaid Innovation (CMMI) are interested in advancing renal replacement therapies or devices could encourage more investment in medical product development for kidney disease. On a press call Wednesday (July 17), foundation leaders said key to getting new products to market is making sure that venture capital groups and pharmaceutical companies invest in research, which can be done by de-risking capital...